Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 01, 2015 1:27 PM ET

Pharmaceuticals

Company Overview of Perrigo Finance Plc

Company Overview

Perrigo Finance Plc is a debt issuing company. The company was formerly known as Elan Finance plc and changed its name to Perrigo Finance Plc in November 2014. The company was incorporated in 2004 and is based in Dublin, Ireland. The company operates as a subsidiary of Perrigo Company Public Limited Company.

Treasury Building

Lower Grand Canal Street

Dublin,  2

Ireland

Founded in 2004

Phone:

353 1 709 4000

Fax:

353 1 709 4700

Key Executives for Perrigo Finance Plc

Secretary and Director
Age: 63
Compensation as of Fiscal Year 2015.

Perrigo Finance Plc Key Developments

Perrigo Finance Plc Announces Closing of the Issuance of $1.6 Billion of Senior Notes Consisting of $500 Million Aggregate Principal Amount of 3.50% Senior Notes Due 2021

On December 2, 2014, Perrigo Finance plc announced the closing of the issuance of $1.6 billion of Senior Notes consisting of $500 million aggregate principal amount of 3.50% Senior Notes due 2021 (the 2021 Notes), $700 million aggregate principal amount of 3.90% Senior Notes due 2024 (the 2024 Notes) and $400 million aggregate principal amount of 4.90% Senior Notes due 2044 (the 2044 Notes and, together with the 2021 Notes and the 2024 Notes, the Notes), pursuant to a supplemental indenture, dated as of December 2, 2014, between the Issuer, the company, as the parent guarantor, and Wells Fargo Bank, National Association, as trustee (the First Supplemental Indenture), to an indenture, dated as of December 2, 2014, between the Issuer, the company and Wells Fargo Bank, National Association, as trustee (the Base Indenture, and together with the First Supplemental Indenture, the Indenture). The Issuer will pay interest on the 2021 Notes at 3.50% per annum, on the 2024 Notes at 3.90% per annum and on the 2044 Notes at 4.90% per annum, semiannually commencing on June 15, 2015. The company intends to use the net proceeds of the offering, together with the proceeds of the company's offering of ordinary shares, which closed on November 26, 2014, and other financing sources, to fund the cash consideration for its proposed acquisition (the Acquisition) of Omega Pharma Invest NV (Omega) and to repay or refinance certain indebtedness of the company and/or Omega. If the Acquisition is not consummated for any reason, then the net proceeds of the offering will be used to redeem the Notes at a redemption price of 101% of the aggregate principal amount of the Notes, plus accrued and unpaid interest to, but not including, the redemption date.

Similar Private Companies By Industry

Company Name Region
BioClin Research Laboratories Ltd. Europe
Altan Pharma Limited Europe
GE Healthcare Ireland Europe
Alkermes Pharma Ireland Limited Europe
Cambrex Cork Limited Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Perrigo Finance Plc, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.